Daniel Capone
Director, Strategy & Operations
RegCell, Inc.
Dan serves as Director of Strategy and Operations at RegCell, Inc., a biotech company pioneering epigenetically reprogrammed regulatory T cell (Treg) therapies for autoimmune disease, built on the foundational Treg biology of co-founder Professor Shimon Sakaguchi. In this capacity, Dan oversees cross-functional teams responsible for study planning and execution, budgeting, and manufacturing while managing external partnership activities. Dan brings years of experience starting from the bench as a research scientist before moving into program and alliance management, leading early- and late-stage teams in oncology. Dan holds a Masters in Biomedical Engineering from Tulane University where he studied soft tissue mechanics.
Sessions
-
24-Jun-2026Theater 3RegCell




